HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wella FY 2003

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics & Fragrances division sales are anticipated to grow 15.3% when adjusted for currency and 9% on a nominal basis, German hair care company says in fiscal 2003 preliminary report. Overall consolidated sales were $4.2 bil. (€1= $1.26), an increase of 4.3% adjusted for currency, but down 2.3% on a nominal basis. Earnings will be impacted by negative foreign currency effects, Wella noted. Operating income will be "slightly lower" at $394.7 mil., the firm said, but profit before taxes will be $301.4 mil., a "slight improvement" over prior-year results of $300.3 mil. Commenting on the effects of last year's acquisition by Procter & Gamble, Wella notes that despite "prevailing uncertainty among clients and employees associated with a takeover process, the company is satisfied with this performance." The firm will release complete FY 2003 results on March 4...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011848

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel